Search Results - "Hogdall, Claus K."

Sample Handling for Mass Spectrometric Proteomic Investigations of Human Sera by West-Nielsen, Mikkel, Høgdall, Estrid V, Marchiori, Elena, Høgdall, Claus K, Schou, Christian, Heegaard, Niels H. H

“…Proteomic investigations of sera are potentially of value for diagnosis, prognosis, choice of therapy, and disease activity assessment by virtue of discovering…”
Get full text

Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients : From the 'MALOVA' Ovarian Cancer Study by HOGDALL, Estrid V. S, CHRISTENSEN, Lise, HOGDALL, Claus K, BLAAKAER, Jan, GAYTHER, Simon, JACOBS, Ian J, CHRISTENSEN, Ib Jarle, KJAER, Susanne K

“…Estrogen and progesterone are important hormones secreted by the ovary acting through specific receptors. Tumor tissue expression profiles of these have…”
Get full text

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: From the Danish MALOVA Ovarian Cancer Study by HØGDALL, Estrid V. S, CHRISTENSEN, Lise, KJAER, Susanne K, BLAAKAER, Jan, BOCK, Johannes E, GLUD, Eva, NORGAARD-PEDERSEN, Bent, HOGDALL, Claus K

“…The HER-2 (Human Epidermal Growth factor receptor-2, also known as c-erb-2/neu) protooncogene encodes a transmembrane receptor protein, M(r) 185,000. Studies…”
Get full text

Annexin A2 and cancer: A systematic review by Christensen, Maria V, Høgdall, Claus K, Jochumsen, Kirsten M, Høgdall, Estrid V S

“…Annexin A2 is a 36-kDa protein interfering with multiple cellular processes especially in cancer progression. The present review aimed to show the relations…”
Get full text

Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population by Song, Honglin, Dicks, Ed, Ramus, Susan J, Tyrer, Jonathan P, Intermaggio, Maria P, Hayward, Jane, Edlund, Christopher K, Conti, David, Harrington, Patricia, Fraser, Lindsay, Philpott, Susan, Anderson, Christopher, Rosenthal, Adam, Gentry-Maharaj, Aleksandra, Bowtell, David D, Alsop, Kathryn, Cicek, Mine S, Cunningham, Julie M, Fridley, Brooke L, Alsop, Jennifer, Jimenez-Linan, Mercedes, Høgdall, Estrid, Høgdall, Claus K, Jensen, Allan, Kjaer, Susanne Krüger, Lubiński, Jan, Huzarski, Tomasz, Jakubowska, Anna, Gronwald, Jacek, Poblete, Samantha, Lele, Shashi, Sucheston-Campbell, Lara, Moysich, Kirsten B, Odunsi, Kunle, Goode, Ellen L, Menon, Usha, Jacobs, Ian J, Gayther, Simon A, Pharoah, Paul D P

“…The aim of this study was to estimate the contribution of deleterious mutations in the RAD51B, RAD51C, and RAD51D genes to invasive epithelial ovarian cancer…”
Get full text

Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass by Oliveira, Douglas Nogueira Perez, Carlsen, Anting Liu, Heegaard, Niels H H, Prahm, Kira Philipsen, Christensen, Ib Jarle, Høgdall, Claus K, Høgdall, Estrid V

“…Ovarian cancer is the fifth most common cancer in women worldwide. Moreover, there are no reliable minimal invasive tests to secure the diagnosis of malignant…”
Get full text

Risk factors for lymph node metastasis in women with FIGO 2018 IA cervical cancer with a horizontal spread of > 7 mm by Wenzel, Hans H.B., Schnack, Tine H., Van der Aa, Maaike A., Jensen, Pernille T., Høgdall, Claus K., Hardie, Anna Norberg, Falconer, Henrik, Bekkers, Ruud L.M.

“…In the FIGO 2018 classification, women with cervical cancer and a depth of invasion ≤ 5 mm and a horizontal spread of > 7 mm in excisional biopsy with…”
Get full text

Strategies for data normalization and missing data imputation and consequences for potential diagnostic microRNA biomarkers in epithelial ovarian cancer by Lopacinska-Jørgensen, Joanna, Petersen, Patrick H D, Oliveira, Douglas V N P, Høgdall, Claus K, Høgdall, Estrid V

“…MicroRNAs (miRNAs) are small non-coding RNA molecules regulating gene expression with diagnostic potential in different diseases, including epithelial ovarian…”
Get full text

Integrated microRNA and mRNA signatures associated with overall survival in epithelial ovarian cancer by Lopacinska-Jørgensen, Joanna, Oliveira, Douglas V. N. P, Wayne Novotny, Guy, Høgdall, Claus K, Høgdall, Estrid V

“…Ovarian cancer (OC), the eighth-leading cause of cancer-related death among females worldwide, is mainly represented by epithelial OC (EOC) that can be further…”
Get full text

Gene expression profile association with poor prognosis in epithelial ovarian cancer patients by Oliveira, Douglas V. N. P., Prahm, Kira P., Christensen, Ib J., Hansen, Anker, Høgdall, Claus K., Høgdall, Estrid V.

“…Ovarian cancer (OC) is the eighth most common type of cancer for women worldwide. The current diagnostic and prognostic routine available for OC management…”
Get full text

HE4 tissue expression and serum HE4 levels in healthy individuals and patients with benign or malignant tumors: a systematic review by Karlsen, Nikoline S, Karlsen, Mona A, Høgdall, Claus K, Høgdall, Estrid V S

“…Human epididymis protein 4 (HE4) has received major attention as a potential tumor marker in epithelial ovarian cancer; however, evidence of significant…”
Get full text

Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer by Dehn, Hannah, Høgdall, Estrid V S, Johansen, Julia S, Jørgensen, Morten, Price, Paul A, Engelholm, Svend A A, Høgdall, Claus K

“…YKL-40, a member of family 18 glycosyl hydrolases, is secreted by cancer cells. The function of YKL-40 in cancer diseases is unknown, but it is a growth factor…”
Get more information

Oncomine™ Comprehensive Assay v3 vs. Oncomine™ Comprehensive Assay Plus by Vestergaard, Lau K., Oliveira, Douglas N. P., Poulsen, Tim S., Høgdall, Claus K., Høgdall, Estrid V.

“…The usage of next generation sequencing in combination with targeted gene panels has enforced a better understanding of tumor compositions. The identification…”
Get full text

Paired comparison of the analytical performance between the Oncomine™ Comprehensive Assay v3 and whole-exome sequencing of ovarian cancer tissue by Lopacinska-Jørgensen, Joanna, Vestergaard, Lau K., Schejbel, Lone, Høgdall, Claus K., Poulsen, Tim Svenstrup, Høgdall, Estrid V.

“…Background Next-generation sequencing (NGS) has been implemented in clinical oncology as a personalized medicine tool to identify targetable genetic…”
Get full text

A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer — An international multicenter study in women with an ovarian mass by Karlsen, Mona A, Høgdall, Estrid V.S, Christensen, Ib J, Borgfeldt, Christer, Kalapotharakos, Grigorios, Zdrazilova-Dubska, Lenka, Chovanec, Josef, Lok, Christianne A.R, Stiekema, Anna, Mutz-Dehbalaie, Irene, Rosenthal, Adam N, Moore, Elizabeth K, Schodin, Beth A, Sumpaico, Walfrido W, Sundfeldt, Karin, Kristjansdottir, Björg, Zapardiel, Ignacio, Høgdall, Claus K

“…Abstract Aim To develop and validate a biomarker-based index to optimize referral and diagnosis of patients with suspected ovarian cancer. Furthermore, to…”
Get full text

Identification of stably expressed microRNAs in plasma from high-grade serous ovarian carcinoma and benign tumor patients by Petersen, Patrick H.D., Lopacinska-Jørgensen, Joanna, Høgdall, Claus K., Høgdall, Estrid V.

“…Background Ovarian cancer is a lethal gynecological cancer and no reliable minimally invasive early diagnosis tools exist. High grade serous ovarian carcinoma…”
Get full text

Next Generation Sequencing Technology in the Clinic and Its Challenges by Vestergaard, Lau K, Oliveira, Douglas N P, Høgdall, Claus K, Høgdall, Estrid V

“…Data analysis has become a crucial aspect in clinical oncology to interpret output from next-generation sequencing-based testing. NGS being able to resolve…”
Get full text

Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer by Quinn, Michael C J, McCue, Karen, Shi, Wei, Johnatty, Sharon E, Beesley, Jonathan, Civitarese, Andrew, O'Mara, Tracy A, Glubb, Dylan M, Tyrer, Jonathan P, Armasu, Sebastian M, Ong, Jue-Sheng, Gharahkhani, Puya, Lu, Yi, Gao, Bo, Patch, Ann-Marie, Fasching, Peter A, Beckmann, Matthias W, Lambrechts, Diether, Vergote, Ignace, Velez Edwards, Digna R, Beeghly-Fadiel, Alicia, Benitez, Javier, Garcia, Maria J, Goodman, Marc T, Dörk, Thilo, Dürst, Matthias, Modugno, Francesmary, Moysich, Kirsten, du Bois, Andreas, Pfisterer, Jacobus, Bauman, Klaus, Karlan, Beth Y, Lester, Jenny, Cunningham, Julie M, Larson, Melissa C, McCauley, Bryan M, Kjaer, Susanne K, Jensen, Allan, Hogdall, Claus K, Hogdall, Estrid, Schildkraut, Joellen M, Riggan, Marjorie J, Berchuck, Andrew, Cramer, Daniel W, Terry, Kathryn L, Bjorge, Line, Webb, Penelope M, Friedlander, Michael, Pejovic, Tanja, Moffitt, Melissa, Glasspool, Rosalind, May, Taymaa, Ene, Gabrielle E V, Huntsman, David G, Woo, Michelle, Carney, Michael E, Hinsley, Samantha, Heitz, Florian, Fereday, Sian, Kennedy, Catherine J, Edwards, Stacey L, Winham, Stacey J, deFazio, Anna, Pharoah, Paul D P, Goode, Ellen L, MacGregor, Stuart, Chenevix-Trench, Georgia

“…Many loci have been found to be associated with risk of epithelial ovarian cancer (EOC). However, although there is considerable variation in progression-free…”
Get full text

Methylation and ovarian cancer: Can DNA methylation be of diagnostic use? by Hentze, Julie L, Høgdall, Claus K, Høgdall, Estrid V

“…Ovarian cancer is a silent killer and, due to late diagnosis and frequent chemo resistance in patients, the primary cause of fatality amongst the various types…”
Get full text

Robot-assisted surgery in gynecological oncology: current status and controversies on patient benefits, cost and surgeon conditions - a systematic review by Kristensen, Steffen E, Mosgaard, Berit J, Rosendahl, Mikkel, Dalsgaard, Tórur, Bjørn, Signe F, Frøding, Ligita P, Kehlet, Henrik, Høgdall, Claus K, Lajer, Henrik

“…Robot-assisted surgery has become more widespread in gynecological oncology. The purpose of this systematic review is to present current knowledge on…”
Get more information